BridgeBio Oncology Therapeutics Price Chart
BridgeBio Oncology Therapeutics Volume Chart
BridgeBio Oncology Therapeutics Market Segments
Overnight
*No Trades in Segment
After Hours
+0.11(+1.19%)
| Open | $9.23 |
|---|---|
| Close | $9.34 |
| Low | $9.23 |
| Low Change | 0.00 (0.00%) |
| High | $9.34 |
| High Change | +0.11 (+1.19%) |
| Range | $0.11 |
| Volume | 25.165K |
| Dollar Volume | $235.04K |
Regular Trading Hours
-0.23(-2.43%)
| Open | $9.48 |
|---|---|
| Close | $9.25 |
| Low | $9.20 |
| Low Change | -0.28 (-2.95%) |
| High | $9.61 |
| High Change | +0.13 (+1.37%) |
| Range | $0.41 |
| Volume | 263.591K |
| Dollar Volume | $2.44M |
Premarket
*No Trades in Segment
After Hours Yesterday
+0.11(+1.19%)
| Open | $9.23 |
|---|---|
| Close | $9.34 |
| Low | $9.23 |
| Low Change | 0.00 (0.00%) |
| High | $9.34 |
| High Change | +0.11 (+1.19%) |
| Range | $0.11 |
| Volume | 25.165K |
| Dollar Volume | $235.04K |
Regular Trading Hours Yesterday
-0.23(-2.43%)
| Open | $9.48 |
|---|---|
| Close | $9.25 |
| Low | $9.20 |
| Low Change | -0.28 (-2.95%) |
| High | $9.61 |
| High Change | +0.13 (+1.37%) |
| Range | $0.41 |
| Volume | 263.591K |
| Dollar Volume | $2.44M |
Premarket Yesterday
*No Trades in Segment
BridgeBio Oncology Therapeutics News
BridgeBio Oncology Therapeutics Top Trades
BridgeBio Oncology Therapeutics's top trade so far today returned +1.52%, while the top short trade returned -3.95%.
BridgeBio Oncology Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $9.30 |
|---|---|
| 10 Day Moving Average (SMA10) | $8.94 |
| 20 Day Moving Average (SMA20) | $8.78 |
| 50 Day Moving Average (SMA50) | $8.28 |
| 100 Day Moving Average (SMA100) | $8.49 |
| 200 Day Moving Average (SMA200) | $10.03 |
BridgeBio Oncology Therapeutics Statistics
| Average Volume (30 Days) | 327.58K |
|---|---|
| P/E Ratio (Current) | -4.15 |
| EPS (Current) | -$2.27 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$193.82M |
| Cash Ratio | 1.05 |
| Current Ratio | 4.69 |
| Quick Ratio | 4.69 |
| Debt to Equity | 0.00 |
| Enterprise Value | $701.18M |
| EV to EBITDA | -3.54 |
| EV to Sales | — |
| Price to Book | 2.34 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | -0.48% |
| Return on Equity | -0.56% |
BridgeBio Oncology Therapeutics Stock Splits
There have been no stock splits for BridgeBio Oncology Therapeutics (BBOT).
BridgeBio Oncology Therapeutics Dividends
There have been no dividends for BridgeBio Oncology Therapeutics (BBOT).